-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-508158-24-00
4
2024-06-25
Moderately to Severely Active Crohn’s Disease
-
2023-506150-21-00
4
2024-05-29
Celiac Disease
-
2023-506308-24-00
10
2024-05-22
Recurrent or metastatic head and neck squamous cell carcinoma
-
2023-505929-14-00
5
2024-05-21
Systemic Lupus Erythematosus
-
2023-503631-18-01
5
2024-05-20
Nervous system diseases
-
2023-504151-27-00
5
2024-05-09
Psychosis associated with Alzheimer’s Disease
-
2023-504899-25-00
5
2024-04-04
Metastatic castration resistant prostate cancer
-
2023-504923-20-00
5
2024-04-04
Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer
-
2023-504031-41-00
5
2024-03-25
ER+/HER2- Early Breast Cancer
-
2023-503376-24-00
5
2024-03-20
Metastatic non-small cell lung cancer (NSCLC)
-
2022-502282-24-00
5
2024-02-14
Primary generalized tonic-clonic seizures
-
2022-502113-28-00
5
2024-02-01
Follicular lymphoma
-
2023-503327-26-00
5
2024-01-31
Sjogren's syndrome
-
2022-502980-39-00
5
2024-01-25
Estrogen receptor (ER)-positive, HER2-negative advanced breast cancer
-
2022-503092-28-00
5
2024-01-08
Relapsed/Refractory Follicular Lymphoma
-
2022-502046-28-00
5
2023-12-22
HER2-Positive, PIK3CA Mutated, Locally Advanced or Metastatic Breast C
-
2022-502193-16-00
5
2023-11-14
Chronic lymphocytic leukemia, Multiple Myeloma and Non-Hodgkin Lymphom
-
2022-501515-14-00
5
2023-09-29
Newly Diagnosed Multiple Myeloma (NDMM)
-
2022-502851-79-00
5
2023-09-20
Active Idiopathic Inflammatory Myopathy (IIM)
-
2022-502732-39-00
10
2023-09-01
Previously treated non-ocular advanced melanoma
-
2024-513006-61-00
3
2023-08-23
Advanced and/or metastatic solid tumours (colorectal cancer, ovarian
-
2022-500967-11-00
5
2023-07-06
Previously Untreated Metastatic or Unresectable Melanoma
-
2022-500699-76-00
5
2023-05-18
Active Systemic Lupus Erythematosus (SLE)